[New possibilities of herpes simplex therapy in the dermatological practice].
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000956:Antigens, Viral / Q000008:administration & dosage / Q000009:adverse effects; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000209:etiology; D006560:Herpes Labialis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy* / Q000628:therapy; D006563:Herpes Zoster Ophthalmicus / Q000188:drug therapy; D006564:Herpesviridae / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D007167:Immunotherapy / Q000009:adverse effects; D008297:Male; D009059:Mouth Diseases; D009824:Ointments; D011239:Prednisolone / Q000627:therapeutic use*; D014529:Uridine / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D000956:Antigens, Viral; D009824:Ointments; D011239:Prednisolone; D014529:Uridine; D004121:Dimethyl Sulfoxide
Neue Behandlungsmöglichkeiten des Herpes simplex in der dermatologischen Praxis.